Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report aims to provide a comprehensive presentation of the global market for Liposomes Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Drug Delivery. This report contains market size and forecasts of Liposomes Drug Delivery in global, including the following market information:
Global Liposomes Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Liposomes Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Vials)
Global top five Liposomes Drug Delivery companies in 2022 (%)
The global Liposomes Drug Delivery market was valued at US$ 3431.8 million in 2022 and is projected to reach US$ 6506.7 million by 2029, at a CAGR of 9.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
We surveyed the Liposomes Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Vials)
Global Liposomes Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Global Liposomes Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Vials)
Global Liposomes Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Global Liposomes Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Vials)
Global Liposomes Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposomes Drug Delivery revenues share in global market, 2022 (%)
Key companies Liposomes Drug Delivery sales in global market, 2018-2023 (Estimated), (K Vials)
Key companies Liposomes Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomes Drug Delivery, market overview.
Chapter 2: Global Liposomes Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomes Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liposomes Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomes Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomes Drug Delivery Overall Market Size
2.1 Global Liposomes Drug Delivery Market Size: 2022 VS 2029
2.2 Global Liposomes Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Liposomes Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Liposomes Drug Delivery Players in Global Market
3.2 Top Global Liposomes Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes Drug Delivery Revenue by Companies
3.4 Global Liposomes Drug Delivery Sales by Companies
3.5 Global Liposomes Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Liposomes Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liposomes Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomes Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposomes Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposomes Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Liposomes Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type - Global Liposomes Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposomes Drug Delivery Sales, 2018-2023
4.3.2 By Type - Global Liposomes Drug Delivery Sales, 2024-2029
4.3.3 By Type - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
4.4 By Type - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomes Drug Delivery Market Size, 2022 & 2029
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposomes Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposomes Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Liposomes Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application - Global Liposomes Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposomes Drug Delivery Sales, 2018-2023
5.3.2 By Application - Global Liposomes Drug Delivery Sales, 2024-2029
5.3.3 By Application - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
5.4 By Application - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Liposomes Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Liposomes Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposomes Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Liposomes Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region - Global Liposomes Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposomes Drug Delivery Sales, 2018-2023
6.3.2 By Region - Global Liposomes Drug Delivery Sales, 2024-2029
6.3.3 By Region - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Liposomes Drug Delivery Revenue, 2018-2029
6.4.2 By Country - North America Liposomes Drug Delivery Sales, 2018-2029
6.4.3 US Liposomes Drug Delivery Market Size, 2018-2029
6.4.4 Canada Liposomes Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Liposomes Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Liposomes Drug Delivery Revenue, 2018-2029
6.5.2 By Country - Europe Liposomes Drug Delivery Sales, 2018-2029
6.5.3 Germany Liposomes Drug Delivery Market Size, 2018-2029
6.5.4 France Liposomes Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Liposomes Drug Delivery Market Size, 2018-2029
6.5.6 Italy Liposomes Drug Delivery Market Size, 2018-2029
6.5.7 Russia Liposomes Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Liposomes Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Liposomes Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Liposomes Drug Delivery Revenue, 2018-2029
6.6.2 By Region - Asia Liposomes Drug Delivery Sales, 2018-2029
6.6.3 China Liposomes Drug Delivery Market Size, 2018-2029
6.6.4 Japan Liposomes Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Liposomes Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Liposomes Drug Delivery Market Size, 2018-2029
6.6.7 India Liposomes Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Liposomes Drug Delivery Revenue, 2018-2029
6.7.2 By Country - South America Liposomes Drug Delivery Sales, 2018-2029
6.7.3 Brazil Liposomes Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Liposomes Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomes Drug Delivery Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Liposomes Drug Delivery Sales, 2018-2029
6.8.3 Turkey Liposomes Drug Delivery Market Size, 2018-2029
6.8.4 Israel Liposomes Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Liposomes Drug Delivery Market Size, 2018-2029
6.8.6 UAE Liposomes Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomes Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Liposomes Drug Delivery Major Product Offerings
7.2.4 Gilead Sciences Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Pacira
7.3.1 Pacira Company Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Liposomes Drug Delivery Major Product Offerings
7.3.4 Pacira Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Pacira Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Company Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposomes Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Luye Pharma Key News & Latest Developments
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Company Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Liposomes Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Sigma-Tau Group Key News & Latest Developments
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Company Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Major Product Offerings
7.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Fudan-Zhangjiang Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 CSPC
7.9.1 CSPC Company Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Liposomes Drug Delivery Major Product Offerings
7.9.4 CSPC Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 CSPC Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposomes Drug Delivery Major Product Offerings
7.10.4 Novartis Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Kingond Pharm
7.11.1 Kingond Pharm Company Summary
7.11.2 Kingond Pharm Liposomes Drug Delivery Business Overview
7.11.3 Kingond Pharm Liposomes Drug Delivery Major Product Offerings
7.11.4 Kingond Pharm Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.11.5 Kingond Pharm Key News & Latest Developments
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Company Summary
7.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Business Overview
7.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Major Product Offerings
7.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.12.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.13 Shanghai New Asia
7.13.1 Shanghai New Asia Company Summary
7.13.2 Shanghai New Asia Liposomes Drug Delivery Business Overview
7.13.3 Shanghai New Asia Liposomes Drug Delivery Major Product Offerings
7.13.4 Shanghai New Asia Liposomes Drug Delivery Sales and Revenue in Global (2018-2023)
7.13.5 Shanghai New Asia Key News & Latest Developments
8 Global Liposomes Drug Delivery Production Capacity, Analysis
8.1 Global Liposomes Drug Delivery Production Capacity, 2018-2029
8.2 Liposomes Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomes Drug Delivery Supply Chain Analysis
10.1 Liposomes Drug Delivery Industry Value Chain
10.2 Liposomes Drug Delivery Upstream Market
10.3 Liposomes Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Liposomes Drug Delivery in Global Market
Table 2. Top Liposomes Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liposomes Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Liposomes Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Liposomes Drug Delivery Sales by Companies, (K Vials), 2018-2023
Table 6. Global Liposomes Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Liposomes Drug Delivery Price (2018-2023) & (USD/Vial)
Table 8. Global Manufacturers Liposomes Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2018-2023
Table 15. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2024-2029
Table 16. By Application ? Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2018-2023
Table 20. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2024-2029
Table 21. By Region ? Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2018-2023
Table 25. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2024-2029
Table 26. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2018-2023
Table 29. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2024-2029
Table 30. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2018-2023
Table 33. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2024-2029
Table 34. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2018-2023
Table 37. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2024-2029
Table 38. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2018-2023
Table 41. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2024-2029
Table 42. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2018-2023
Table 45. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Liposomes Drug Delivery Product Offerings
Table 48. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Liposomes Drug Delivery Product Offerings
Table 52. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. Pacira Company Summary
Table 55. Pacira Liposomes Drug Delivery Product Offerings
Table 56. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 57. Pacira Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 60. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Luye Pharma Company Summary
Table 63. Luye Pharma Liposomes Drug Delivery Product Offerings
Table 64. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 65. Luye Pharma Key News & Latest Developments
Table 66. Sigma-Tau Group Company Summary
Table 67. Sigma-Tau Group Liposomes Drug Delivery Product Offerings
Table 68. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 69. Sigma-Tau Group Key News & Latest Developments
Table 70. Fudan-Zhangjiang Company Summary
Table 71. Fudan-Zhangjiang Liposomes Drug Delivery Product Offerings
Table 72. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 73. Fudan-Zhangjiang Key News & Latest Developments
Table 74. Teva Pharmaceutical Company Summary
Table 75. Teva Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 76. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 77. Teva Pharmaceutical Key News & Latest Developments
Table 78. CSPC Company Summary
Table 79. CSPC Liposomes Drug Delivery Product Offerings
Table 80. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 81. CSPC Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Liposomes Drug Delivery Product Offerings
Table 84. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Kingond Pharm Company Summary
Table 87. Kingond Pharm Liposomes Drug Delivery Product Offerings
Table 88. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 89. Kingond Pharm Key News & Latest Developments
Table 90. Spectrum Pharmaceuticals Company Summary
Table 91. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Offerings
Table 92. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 93. Spectrum Pharmaceuticals Key News & Latest Developments
Table 94. Shanghai New Asia Company Summary
Table 95. Shanghai New Asia Liposomes Drug Delivery Product Offerings
Table 96. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 97. Shanghai New Asia Key News & Latest Developments
Table 98. Liposomes Drug Delivery Production Capacity (K Vials) of Key Manufacturers in Global Market, 2021-2023 (K Vials)
Table 99. Global Liposomes Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Liposomes Drug Delivery Production by Region, 2018-2023 (K Vials)
Table 101. Global Liposomes Drug Delivery Production by Region, 2024-2029 (K Vials)
Table 102. Liposomes Drug Delivery Market Opportunities & Trends in Global Market
Table 103. Liposomes Drug Delivery Market Drivers in Global Market
Table 104. Liposomes Drug Delivery Market Restraints in Global Market
Table 105. Liposomes Drug Delivery Raw Materials
Table 106. Liposomes Drug Delivery Raw Materials Suppliers in Global Market
Table 107. Typical Liposomes Drug Delivery Downstream
Table 108. Liposomes Drug Delivery Downstream Clients in Global Market
Table 109. Liposomes Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liposomes Drug Delivery Segment by Type in 2022
Figure 2. Liposomes Drug Delivery Segment by Application in 2022
Figure 3. Global Liposomes Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposomes Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Liposomes Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. Liposomes Drug Delivery Sales in Global Market: 2018-2029 (K Vials)
Figure 8. The Top 3 and 5 Players Market Share by Liposomes Drug Delivery Revenue in 2022
Figure 9. By Type - Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 11. By Type - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 12. By Type - Global Liposomes Drug Delivery Price (USD/Vial), 2018-2029
Figure 13. By Application - Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Application - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 16. By Application - Global Liposomes Drug Delivery Price (USD/Vial), 2018-2029
Figure 17. By Region - Global Liposomes Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Liposomes Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 20. By Region - Global Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 21. By Country - North America Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 22. By Country - North America Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 23. US Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 28. Germany Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. France Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 37. China Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. India Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 43. By Country - South America Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 44. Brazil Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Liposomes Drug Delivery Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Liposomes Drug Delivery Sales Market Share, 2018-2029
Figure 48. Turkey Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Liposomes Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 52. Global Liposomes Drug Delivery Production Capacity (K Vials), 2018-2029
Figure 53. The Percentage of Production Liposomes Drug Delivery by Region, 2022 VS 2029
Figure 54. Liposomes Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
